Dengue surveillance in preparation for field vaccine trials

Journal of Clinical Virology

Volumn 46, Issue SUPPL. 2, 2009, Pages

  Letson, G William ^a  

^a International Vaccine Institute   (South Korea)

Author keywords

Case definitions and outcomes; Post Phase III surveillance; Trial site selection criteria

Indexed keywords

DENGUE VACCINE;

ARTICLE; CLINICAL PRACTICE; CLINICAL TRIAL; DENGUE; DISEASE COURSE; DISEASE SURVEILLANCE; ENDEMIC DISEASE; FLAVIVIRUS; HUMAN; POPULATION MIGRATION; PRIORITY JOURNAL; SEROTYPE;

CHILD; CLINICAL TRIALS AS TOPIC; DENGUE; DENGUE VACCINES; GEOGRAPHY; HUMANS; POPULATION SURVEILLANCE;

EID: 70349443530     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1386-6532(09)70288-4     Document Type: Article

References (6)

1. Protocol for the Assessment of National Communicable Disease Surveillance and Response Systems. http://www.who.int/csr/resources/publications/surveillance/whocdscsrisr20012.pdf Accessed 30 November 2008.
2. Edelman R., and Hombach J. Guidelines for the clinical evaluation of dengue vaccines in endemic areas: Summary of a World Health Organization Technical Consultation. Vaccine 26 (2008) 4113-4119
3. Clemens J., Naficy A., and Rao M.R. Long-term evaluation of vaccine protection: Methodological issues for phase 3 trials and phase 4 studies. In: Levine M.M., Woodrow G.C., Kaper J.B., and Cobon G.S. (Eds). New Generation Vaccines (1997), Marcel Decker Inc., New York, NY 47-68
4. The Gambia Hepatitis Study Group. The Gambia hepatitis intervention study. Cancer Res 47 (1986) 5782-5787
5. Chotard J., Inskip H.M., Hall A.J., Loik F., Mendy M Whittle H., George M.O., and Lowe Y. The Gambia hepatitis intervention study: Follow up of a cohort of children vaccinated against hepatitis B. J Infect Dis 166 (1992) 764-768
6. The ICH Tripartite Guideline E6(R1). http://www.ich.org